Transgender Woman Breastfeeds Her Baby After Experimental Treatment

  • Transgender Woman Breastfeeds Her Baby After Experimental Treatment

Transgender Woman Breastfeeds Her Baby After Experimental Treatment

The 30-year-old wanted to breastfeed after her pregnant partner said she did not want to do it herself, according to the Transgender Health journal. After a month of treatment, the patient was reportedly producing "droplets" of milk. Each month, they increased her hormones dosages again and at only three months into the vigorous routine, she was able to be the baby's exclusive food source from birth to six weeks.

In the new case, the patient first began taking feminizing hormones in 2011 as part of her gender transition.

The treatment allowed her to develop breasts that looked fully grown without augmentation surgery.

The patient took a gradually increasing regimen of the female hormones progesterone and estradiol, stimulated her chest with a breast milk pump, and took domperidone, a nausea medication known to increase milk production.

In addition to the domperidone, the patient took micronized progesterone and estradiol, while also using a breast pump for five minutes on each breast three times a day.

"The patient breastfed exclusively for six weeks", then began to supplement feedings with formula due to "concerns about insufficient milk volume".

While Reisman and Goldstein's patient took her dose orally, the FDA is reportedly still anxious about the possible effects of domperidone on infants, since the drug is passed through breast milk. There are also cases of transgender men carrying pregnancies and breastfeeding, she said.

The medical regimen was administered by Dr. Tamar Reisman and nurse practitioner Zil Goldstein at the Mount Sinai clinic.

Despite the success by the two doctors, more research needs to be conducted to discover the optimal treatment regimen. Though used in many countries, including in Britain, it has been banned in the United States because of Food and Drug Administration concerns about its associations with cardiac arrest and sudden death. The baby is now 6 months old, and is growing and feeding normally, the report said.

Dr Reisman said that the FDA's reluctance to approve domperidone is partly to do with reports of patients injecting the gastric drug intravenously, and developing cardiac issues. "For all we know, breast stimulation alone might be sufficient".

The baby's growth and feeding habits were all normal, said the report.

Also, the hormones involved in inducing lactation can lead to mood swings and weight gain, which can be a deterrent for some people, she said. "At the time of this article submission, the baby is approaching 6 months old".